摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[[3-(三氟甲基)苯基]甲基]哌啶-4-胺 | 66898-97-3

中文名称
1-[[3-(三氟甲基)苯基]甲基]哌啶-4-胺
中文别名
——
英文名称
1-(3-TRIFLUOROMETHYLBENZYL)-4-PIPERIDINYLAMINE
英文别名
1-(3-trifluoromethyl-benzyl)-piperidin-4-ylamine;4-amino-1-(3-trifluoromethylbenzyl)piperidine;1-{[3-(Trifluoromethyl)phenyl]methyl}piperidin-4-amine;1-[[3-(trifluoromethyl)phenyl]methyl]piperidin-4-amine
1-[[3-(三氟甲基)苯基]甲基]哌啶-4-胺化学式
CAS
66898-97-3
化学式
C13H17F3N2
mdl
MFCD09944239
分子量
258.287
InChiKey
BGXWETBTBPDHLX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.0
  • 重原子数:
    18.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.538
  • 拓扑面积:
    29.26
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933399090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[[3-(三氟甲基)苯基]甲基]哌啶-4-胺乙醇 为溶剂, 反应 24.0h, 生成 2-[trans-(4-aminocyclohexyl)amino]-6-[4-[1-(3-trifluoromethylbenzyl)]piperidinylamino]-9-cyclopentylpurine
    参考文献:
    名称:
    THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III
    摘要:
    Cyclin-dependent kinases (CDKs) belong to a class of enzymes that control the ability of a cell to enter into and proceed through the cell division cycle. Using purine as a scaffold, we have synthesized a number of nanomolar inhibitors of CDK-2/cyclin E. In this report, the synthesis of a series of piperidine-substituted purine analogs will be presented, as well as some of their in vitro and in vivo biological effects.
    DOI:
    10.1081/ncn-100002493
  • 作为产物:
    描述:
    1-氯甲基-3-三氟甲基苯caesium carbonate[双(三氟乙酰氧基)碘]苯 、 potassium iodide 作用下, 以 乙腈 为溶剂, 反应 5.0h, 生成 1-[[3-(三氟甲基)苯基]甲基]哌啶-4-胺
    参考文献:
    名称:
    THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III
    摘要:
    Cyclin-dependent kinases (CDKs) belong to a class of enzymes that control the ability of a cell to enter into and proceed through the cell division cycle. Using purine as a scaffold, we have synthesized a number of nanomolar inhibitors of CDK-2/cyclin E. In this report, the synthesis of a series of piperidine-substituted purine analogs will be presented, as well as some of their in vitro and in vivo biological effects.
    DOI:
    10.1081/ncn-100002493
点击查看最新优质反应信息

文献信息

  • Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
    申请人:Dow AgroSciences LLC
    公开号:US06355660B1
    公开(公告)日:2002-03-12
    A compound having the following formula: wherein R3 and M are defined herein, and processes therewith.
    具有以下公式的化合物: 其中R3和M的定义如本文所述,以及与此相关的过程。
  • [EN] NOVEL COMPOUNDS AS CALCIUM CHANNEL BLOCKERS<br/>[FR] NOUVEAUX COMPOSÉS UTILISÉS COMME BLOQUEURS DES CANAUX CALCIQUES
    申请人:ABBOTT LAB
    公开号:WO2010039947A1
    公开(公告)日:2010-04-08
    The present application relates to calcium channel inhibitors containing compounds of formula (I) wherein Ar1, Ar2, L1, L2, n, R1, R4, X and Y are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
    本申请涉及含有式(I)化合物的钙通道抑制剂,其中Ar1、Ar2、L1、L2、n、R1、R4、X和Y如规范中所定义。本申请还涉及包含这些化合物的组合物,以及使用这些化合物和组合物治疗疾病和疾病的方法。
  • ACTIVATOR OF ADIPONECTIN RECEPTOR
    申请人:THE UNIVERSITY OF TOKYO
    公开号:US20160214967A1
    公开(公告)日:2016-07-28
    An AdipoR activator for activating both AdipoR1 and AdipoR2 is provided. A compound represented by the following formula (1), wherein A is a substituted or unsubstituted aryl group or the like, Y 1 is (CHR 2 ) a — or the like, X is CH or N, R 1 is a C 1-7 alkyl group, m is an integer of 0-4, Y 2 is *—O—CH 2 —CONH—, *—CONH—(CH 2 ) b —CO— or the like, Z is a cyclic group, B may be a substituent of the cyclic group represented by Z, and n is an integer of 0-3.
    提供了一种用于激活AdipoR1和AdipoR2的AdipoR激活剂。以下式(1)表示的化合物,其中A是取代或未取代的芳基或类似物,Y1是(CHR2)a—或类似物,X是CH或N,R1是C1-7烷基基团,m是0-4的整数,Y2是*—O—CH2—CONH—,*—CONH—(CH2)b—CO—或类似物,Z是环基团,B可以是Z代表的环基团的取代基,n是0-3的整数。
  • Antihypertensive isoindole derivatives
    申请人:Mead Johnson & Company
    公开号:US04495194A1
    公开(公告)日:1985-01-22
    Novel phthalimide intermediates are reduced to 5-sulfamoyl-6-halo-3-oxoisoindole compounds bearing a substituted 1-phenylalkyl-4-piperidinyl moiety as the isoindole N-substituent. Preferred compounds such as 6-chloro-2,3-dihydro-3-oxo-2-[1-(phenylmethyl)-4-piperidinyl]-1H-isoindole -5-sulfonamide exhibit diuretic and antihypertensive properties.
    新型邻苯二甲酰亚胺中间体被还原为携带取代的1-苯基烷基-4-哌啶基团作为异吲哚N-取代基的5-磺胺基-6-卤代-3-酮异吲哚化合物。首选化合物,如6-氯-2,3-二氢-3-酮-2-[1-(苯基甲基)-4-哌啶基]-1H-异吲哚-5-磺胺酰胺,具有利尿和降压作用。
  • Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
    申请人:American Home Products Corporation
    公开号:US05438064A1
    公开(公告)日:1995-08-01
    Derivatives of 4-anilinoquinoline having the formula: ##STR1## where X is O or H.sub.2 and Z is 1-substituted-4-piperidinylamino or diloweralkylaminoloweralkyl inhibit binding of tritiated bradykinin to guinea pig ileum and inhibit bradykinin-induced writhing in mice. Bradykinin is a nonapeptide formed in plasma as a result of inflammation or injury and produces pain when it binds with pain receptors. A drug which inhibits the binding of bradykinin therefore has analgetic properties.
    4-苯胺基喹啉的衍生物具有以下公式:## STR1 ## 其中X为O或H.sub.2,Z为1-取代-4-哌啶基氨基或双低烷基氨基低烷基。该化合物能够抑制三氚-缓激肽在豚鼠回肠上的结合,并且可以抑制缓激肽诱导的小鼠扭动反应。缓激肽是一种非九肽,由于炎症或损伤而在血浆中形成,当它与疼痛受体结合时会产生疼痛。因此,抑制缓激肽的结合具有镇痛作用。
查看更多